Study: Guillain–Barré syndrome risk with COVID-19 vaccines low, but higher with J&J shot

The risk for developing Guillain-Barré syndrome, a condition that causes severe muscle weakness, after receipt of a COVID-19 vaccine is small, but higher with the Johnson & Johnson shot, according to a study.